IP Library Granted Patent US 12,308,096
Granted Patent B2
US 12,308,096 · App. 18/119,992 · Granted May 20, 2025

Computer device for detecting an optimal candidate compound and methods thereof

Inventors: Emmanuel Israel Fuentes (Waukesha, WI); Gopal Biligeri Avinash (San Ramon, CA); Robert John Graves (San Ramon, CA); Abhijit Vijay Thatte (San Ramon, CA); Afek Kodesh (San Ramon, CA); Jeffery Caron (San Ramon, CA); Sharmistha Das (San Ramon, CA)
Assignee: Molecular Devices, LLC
G16C20/50G06F18/2321G06T7/0012G06T7/0014G06V10/763G06V20/698G16B20/00G01N33/5008G06F2218/16G06T2200/24G06T2207/30024
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,308,096
App. No.
18/119,992
Granted
May 20, 2025
Kind
B2
Abstract

The invention relates to a method for a computer device, for detecting an optimal candidate compound based on a plurality of samples comprising a cell line and one or more biomarkers, and a plate map configuration, wherein the plate map configuration is providing locations of samples comprising cell lines exposed to one or more biomarkers and different concentrations of a candidate compound forming at least one concentration gradient, the candidate compound being comprised in a plurality of can-didate compounds, said method comprising generating ( 310 ) phenotypic profiles of each concentration gradient of each of the plurality of candidate compounds at a plurality of successive points in time to form a plurality of compound profiles, wherein generating phenotypic profiles comprises the steps obtaining ( 312 ) image data depicting each sample comprised in the concentration gradient, generating ( 314 ) a class-label and a class for each cell of the samples based on the image data, detecting ( 320 ) the optimal candidate compound by evaluating a comparison criterion on the plurality of compound profiles. Furthermore, the invention also relates to corre-sponding computer device, a computer program, and a computer program product.

Claims (43)

1. A computer-implemented method for generating class-labels and/or classes for cells comprising:

obtaining image data associated with a plurality of samples of a cell line treated with a biomarker and subjected to experimental perturbation;

segmenting, by a processor, cell objects from the obtained image data;

generating a set of class-labels corresponding to each of the cell objects;

running an unsupervised clustering algorithm on the processor to classify each of the cell objects with a corresponding one of the set of class-labels;

displaying at least one cell object and the respective class-label;

receiving data indicative of an operation on at least one class-label; and

performing the operation on the class-label by the processor based on the received data.

2. The method of claim 1 , wherein experimental perturbation comprises at least one of: inhibiting enzyme activities in cells, promoting enzyme activities in cells, genetic modification of cells, or applying a candidate compound to cells.

3. The method of claim 2 wherein applying a candidate compound comprises applying different concentrations of the candidate compound to the cells forming a concentration gradient.

4. The method of claim 1 , wherein the operation comprises one of add class, delete class, split class, and merge class.

5. The method of claim 1 , wherein displaying at least one cell object and the respective class-label comprises displaying an exemplary cell object and the respective class-label and/or class comprises:

calculating a confidence measure of how well each cell object represents the class-label; and

selecting the exemplary cell object as the cell object with the highest confidence measure.

6. The method of claim 1 wherein the class-label is indicative of cell health status or cell cycle status.

7. The method of claim 1 , further comprising generating phenotypic profiles of a concentration gradient for a candidate compound at each of a plurality of successive points in time to form a compound profile.

8. The method of claim 7 , further comprising forming a first collection of cytometric parameter sets by generating a cytometric parameter set for each cell object based on the image data.

9. The method of claim 1 , further comprising storing at a memory a phenotypic classification model based upon the class-labels, wherein the phenotypic classification model is configured to map a cytometric parameter set to a class, based on a parameter similarity function.

10. The method of claim 9 , wherein the parameter similarity function is a multi-dimensional correlation function configured to operate over two or more cytometric parameter sets.

11. The method of claim 10 , wherein the parameter similarity function is a machine learning algorithm selected from the group consisting of: self-organizing maps, auto -encoders, Ward Clustering, K-Means Clustering, and t-SNE Dimensionality Reduction.

12. The method of claim 1 , further comprising:

detecting an optimal candidate compound selected from one or more reference compound profiles and based on the experimental perturbation; and

calculating a multi-dimensional differential value for each of the one or more reference compound profiles based on the experimental perturbation.

13. A system comprising:

a computer-readable medium storing instructions that, when executed by a processor:

obtain, by the processor, image data associated with a plurality of samples of a cell line treated with a biomarker and subjected to experimental perturbation;

segment cell objects from the obtained image data;

generate a set of class-labels corresponding to each of the cell objects; and

run an unsupervised clustering algorithm on the processor to classify each of the cell objects with a corresponding one of the set of class-labels;

render for display at least one cell object and respective class-label from the obtained image data, wherein the rendered displayed at least one cell objects are segmented based upon the classification from the unsupervised clustering algorithm;

receive data indicative of an operation on at least one class-label; and

perform the operation on the class-label by the processor based on the received data.

14. The system of claim 13 , wherein the operation comprises one of add class, delete class, split class, and merge class.

15. The system of claim 13 , wherein displaying at least one cell object and the respective class-label comprises displaying an exemplary cell object and the respective class-label and/or class comprises:

calculating a confidence measure of how well each cell object represents the class-label; and

selecting the exemplary cell object as the cell object with the highest confidence measure.

16. The system of claim 13 , wherein the class-label is indicative of cell health status or cell cycle status.

17. The system of claim 13 , wherein the processor further generates phenotypic profiles of a concentration gradient for a candidate compound at each of a plurality of successive points in time to form a compound profile.

18. The system of claim 17 , wherein the processor further forms a first collection of cytometric parameter sets by generating a cytometric parameter set for each cell object based on the image data.

19. The system of claim 13 , further comprising storing at the computer -readable medium a phenotypic classification model based upon the class-labels, wherein the phenotypic classification model is configured to map a cytometric parameter set to a class, based on a parameter similarity function.

20. The system of claim 13 , wherein the processor is further configured to:

detect an optimal candidate compound selected from one or more reference compound profiles and based on the experimental perturbation; and

calculate a multi-dimensional differential value for each of the one or more reference compound profiles based on the experimental perturbation.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2024
From: FUENTES, EMMANUEL ISRAEL; AVINASH, GOPAL BILIGERI; GRAVES, ROBERT JOHN; THATTE, ABHIKIT VIJAY; KODESH, AFEK; CARON, JEFFERY
To: GE HEALTHCARE BIO-SCIENCES CORP.
Reel/Frame 068220/0677 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2024
From: GLOBAL LIFE SCIENCES SOLUTIONS USA LLC
To: MOLECULAR DEVICES, LLC
Reel/Frame 068220/0919 →
CHANGE OF NAME Recorded Aug 8, 2024
From: GE HEALTHCARE BIO-SCIENCES CORP.
To: GLOBAL LIFE SCIENCES SOLUTIONS USA LLC
Reel/Frame 068513/0086 →
Continuity (3)
Continuation 16336549
Provisional Application 62402272 · Sep 30, 2016
Related Publication 20240013867A1 · Jan 11, 2024
References Cited (54)
US 6615141B1 · Sabry · 2003 [cited by applicant]
US 7246012B2 · Kutsyy · 2007 [cited by examiner]
US 8664363B2 · Jones · 2014 [cited by examiner]
US 9796505B1 · Venero · 2017 [cited by examiner]
US 10360499B2 · Kumar · 2019 [cited by examiner]
US 11636924B2 · Fuentes et al. · 2023 [cited by applicant]
US 11861881B2 · Ianni et al. · 2024 [cited by applicant]
US 20040117124A1 · Kiros et al. · 2004 [cited by applicant]
US 20060045348A1 · Kiros · 2006 [cited by examiner]
US 20070208516A1 · Kutsyy et al. · 2007 [cited by applicant]
US 20080280771A1 · Lubman · 2008 [cited by examiner]
US 20090170091A1 · Giuliano · 2009 [cited by applicant]
US 20130101133A1 · Yoon et al. · 2013 [cited by applicant]
US 20130101199A1 · Alexandrov et al. · 2013 [cited by applicant]
US 20160272960A1 · Thanos et al. · 2016 [cited by applicant]
US 20170166878A9 · Thanos et al. · 2017 [cited by applicant]
US 20170272960A1 · Li · 2017 [cited by examiner]
US 20180273621A1 · Damschroder · 2018 [cited by examiner]
US 20190111164A1 · Rainey · 2019 [cited by examiner]
US 20210061906A1 · Damschroder · 2021 [cited by examiner]
US 20210147828A1 · Ben-David · 2021 [cited by examiner]
US 20230360208A1 · Ianni et al. · 2023 [cited by applicant]
US 20240013867A1 · Fuentes et al. · 2024 [cited by applicant]
CN 102165489 · 2011 [cited by applicant]
CN 103827889 · 2014 [cited by applicant]
CN 104204807 · 2014 [cited by applicant]
CN 102687007B · 2015 [cited by applicant]
CN 104975063 · 2015 [cited by applicant]
CN 111656393A · 2020 [cited by applicant]
CN 113454733A · 2021 [cited by applicant]
GB 2434225 · 2007 [cited by applicant]
JP 2009063508 · 2009 [cited by applicant]
JP 2009526519 · 2009 [cited by applicant]
JP 2014134524 · 2014 [cited by applicant]
JP 6445127B2 · 2018 [cited by applicant]
JP 2022532615A · 2022 [cited by applicant]
WO 2012096992 · 2012 [cited by applicant]
WO 2022066725A1 · 2022 [cited by applicant]
WO 2023283321A1 · 2023 [cited by applicant]
Feng et al. (“Multi-Parameter Phenotypic Profiling: Using Cellular Effects to Characterize Small-Molecule compounds,” Drug Discovery, 2009, 8:567-578 (Year: 2009). [cited by examiner]
Abraham et al., “Application of a High-Content Multiparameter Cytotoxicity Assay to Prioritize Compounds Based on Toxicity Potential in Humans,” Society for Biomolecular Sciences, 2008, 527-537. [cited by applicant]
Bodenmiller et al., “Multiplexed Mass Cytometry Profiling of Cellular States Perturbed by Small-Molecule Regulators,” Nature Biotechnology, 2012, 30(9):858-869. [cited by applicant]
Carpenter et al., “CellProfiler: Image Analysis Software for Identifying and Quantifying Cell Phenotypes,” Genome Biology, 2006, 7(10) (11 pages). [cited by applicant]
Chan et al., “Cellometer Vision as an Alternative to Flow Cytometry for Cell Cycle Analysis, Mitochondrial Potential, and Immunophenotyping,” Cytometry Part A, 2011, 79A:507-517. [cited by applicant]
Drawnel et al., “Disease Modeling and Phenotypic Drug Screening for Diabetic Cardiomyopathy Using Human Induced Pluripotent Stem Cells,” Cell Reports, 2014, 9:810-820. [cited by applicant]
European Communication in Application 17787343.7, mailed Nov. 11, 2022, 7 pages. [cited by applicant]
Feng et al., “Multi-Parameter Phenotypic Profiling: Using Cellular Effects to Characterize Small-Molecule Compounds,” Drug Discovery, 2009, 8:567-578. [cited by applicant]
Kawatani, Makoto et al., kemikarubaioroji to shinkibunshihyotekiyaku (chemical biology and novel molecule targeting drugs), Nippon Rinsho, Japan, Aug. 1, 2015, vol. 73, No. 8, Aug. 2015, pp. 1273-1280 (English abstract). [cited by applicant]
Ljosa et al., “Comparison of Methods for Image-Based Profiling of Celolular Morphological Responses to Small-Molecule Treatment,” Journal of Biological Screening, 2013, 18(10): 1321-1329. [cited by applicant]
PCT International Preliminary Report on Patentability in Application PCT/EP2017/075003, mailed Apr. 11, 2019, 8 pgs. [cited by applicant]
PCT International Search Report and Written Opinion in Application PCT/EP2017/075003, mailed May 17, 2018, 11 pgs. [cited by applicant]
Price, Jeffrey et al., “High Throughput Microscopy: From Images to Data”, in 3rd IEEE International Symposium Biomedical Imaging: Nano to Macro, https://ieeexplore.ieee.org/document/1624899, US IEEE, May 8, 2006, pp. 24… [cited by applicant]
European Communication in Application 17787343.7, mailed Apr. 2, 2025, 6 pages. [cited by applicant]
Han, Yuanyuan et al., “Review: Imaging technologies for flow cytometry”, Lab on a Chip, vol. 16, No. 24, Jan. 1, 2016, pp. 4639-4647. [cited by applicant]